A sterile line of Aedes aegypti is developed to fight off arbovirosis

(Fundação de Amparo à Pesquisa do Estado de São Paulo) In Brazil, male specimens with defective sperm are created in lab; manufacturing the transgenic mosquito in large scale could integrate coordinated strategies to control dengue, chikungunya, Zika and yellow fever epidemics.